Percutaneous Coronary Intervention

Platelet inhibition strategies in people with MI undergoing PCI.

Two analyses of large randomized controlled trials suggest that participants not taking medications as prescribed may influence treatment effects and impact study findings, researchers reported.

LOUISVILLE, Ky. — The medical community needs to understand that uncontrolled open artery ischemia is not benign, a speaker said during the American Society for Preventive Cardiology Congress on CVD Prevention.

Pretreatment evolocumab did not lower risk for periprocedural microvascular dysfunction in patients undergoing elective PCI for stable CAD who were already on statin therapy for high LDL, researchers reported.

Compared with conventional IV hydration, furosemide-induced high urine output with matched hydration did not reduce risk for contrast-induced nephropathy in adults with chronic kidney disease undergoing complex CV interventions, data show.

Abbott announced it received FDA approval, CE mark approval in Europe, and Pharmaceuticals and Medical Devices Agency approval in Japan, and has launched new 4.5 mm and 5 mm stent sizes.

Hand function after distal radial artery access vs. proximal artery access in cardiac catheterization.

Safety and efficacy at 5 years with Orsiro Sirolimus Eluting vs. Xience coronary stent systems in up to three native de novo or restenotic coronary artery lesions.

Among adults undergoing PCI, even mild to moderate chronic kidney disease is associated with decreased survival at 1 year in a dose-dependent manner, researchers reported.

Early revascularization may confer mortality benefit in patients with moderate to severe myocardial ischemia identified on nuclear stress testing, regardless of left ventricular ejection fraction, researchers reported.